Cancer Therapy News and Research

RSS

ASTRO develops radiation therapy guideline for treating bone metastases

The American Society for Radiation Oncology Clinical Affairs and Quality Committee has developed a guideline for the use of radiation therapy in treating bone metastases. The guideline will be published in the International Journal of Radiation Oncology-Biology-Physics, an official journal of ASTRO.

17 Feb 2011

Study analyses number of mortality rates among Spanish women with breast cancer

Pioneering Spanish provinces in terms of early prevention of breast cancer, such as Navarre and the Basque Country, record lower death rates, although the trend is towards the figures levelling out all over Spain. These are the results of a study carried out by Spanish researchers, which analyses the number of women who died between 1975 and 2005.

17 Feb 2011

FAK enzyme plays a key role in preparing lung tissue for metastatic development

A Massachusetts General Hospital study has identified a new role for an important enzyme in preparing lung tissue for the development of metastases.

17 Feb 2011

Medtronic: Kyphon Balloon Kyphoplasty provides better back pain relief in cancer patients

Medtronic Inc., today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical care in treating spinal fractures in cancer patients. The study found that Kyphon Balloon Kyphoplasty provided cancer patients better back-specific function, more rapid back pain relief and improved quality of life compared with non-surgical care one month after treatment.

17 Feb 2011

Sonablate HIFU device is now available in Brazil to treat prostate cancer

USHIFU LLC, a world leader in minimally invasive high intensity focused ultrasound technologies and manufacturer of the Sonablate 500 medical device, announces that HIFU with the Sonablate is available to prostate cancer patients for the first time in Brazil at Hospital Nossa Senhora das Gracas in Curitiba, capital city of the state of Parana in southern Brazil.

17 Feb 2011

Oncolytics begins enrollment in 2-Arm carboplatin Phase II randomized study for pancreatic cancer

Oncolytics Biotech Inc. announced today that enrollment has begun in a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.

17 Feb 2011

First lung cancer treatment with BSD's MicroThermX ablation system delivered at Rhode Island Hospital

BSD Medical Corporation today announced the successful delivery of its first lung cancer patient treatment with the MicroThermX® Microwave Ablation System. The treatment was conducted by Damian E. Dupuy, M.D., at The Comprehensive Cancer Center at Rhode Island Hospital in Providence, Rhode Island.

16 Feb 2011

Advaxis added to Mentor Capital Cancer Immunotherapy Index

Mentor Capital, Inc. reports that Advaxis, Inc. has been added as the newest member of the Mentor Capital Cancer Immunotherapy Index.

16 Feb 2011

CTI's fourth quarter net loss increases to $34.1 million

Cell Therapeutics, Inc. today reported recent accomplishments and financial results for the fourth quarter and year ended December 31, 2010.

16 Feb 2011

RPCI offers first FDA-approved cancer treatment vaccine

The nation's first FDA-approved cancer treatment vaccine, Provenge, is being offered for the first time in Western New York at Roswell Park Cancer Institute.

15 Feb 2011

US Oncology's PAPs help cancer patients to access high quality care

Through the continuous and tremendous growth of its patient assistance support program, US Oncology, Inc., a division of McKesson Corp. and a leading integrated oncology company, is helping cancer patients access the high quality cancer care they need. By helping patients obtain financial assistance, thousands can now afford much needed treatment and cancer therapies.

15 Feb 2011

Oncolytics' REOLYSIN/gemcitabine combination Phase 2 pancreatic cancer trial meets primary endpoint

Oncolytics Biotech Inc. today announced preliminary results from a U.S. Phase 2 clinical trial (REO 017) using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar®) in patients with advanced pancreatic cancer. The trial is being conducted at the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio (CTRC).

15 Feb 2011

Researcher discovers mechanism how p53 human genome gets inactivated in cancerous cells

One of the most important genes in the human genome is called p53 and its function is to suppress tumours, according to Roger Leng, a researcher in the Faculty of Medicine & Dentistry. Leng has discovered the mechanism by which p53 is inactivated in cancerous cells, allowing tumours to grow.

15 Feb 2011

Unmet need for medical help to address sexual issues in breast, gynecologic cancer survivors

Many women who survive breast and gynecologic cancers want medical help for their sexual issues, but most do not get it. A survey of hundreds of cancer survivors, published online in the journal Cancer, confirms that more than forty percent want medical attention for their sexual health needs.

15 Feb 2011

State Roundup: Calif. adult day care; S.C.'s budget cuts; Minn. 'boomer bust'

As Gov. Jerry Brown has proposed slashing government aid for poor people, he argues that California still provides more generous benefits than many other states. … State-by-state comparisons are complicated. ... While California pays health costs for a larger share of its population, it spends less per person. It reimburses health care providers less and covers a younger, healthier group of people (Yamamura, 2/14).

14 Feb 2011

OXiGENE, NCI/CTEP and GOG collaborate on ZYBRESTAT Phase 2 study in relapsed ovarian cancer

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has entered into a Cooperative Research and Development Agreement with the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program (CTEP) to collaborate on the conduct of a randomized Phase 2 trial of ZYBRESTAT in combination with bevacizumab in patients with relapsed ovarian cancer.

14 Feb 2011

Cancer cells 'addicted' to self-preservation process

A team of investigators at The Cancer Institute of New Jersey (CINJ); Rutgers, The State University of New Jersey; and Princeton University, have determined that cancer cells are "addicted" to a self-preservation process known as autophagy. They also showed that the inhibition of that process could prove to be a valuable treatment approach for aggressive cancers. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

11 Feb 2011

Genta initiates new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer

Genta Incorporated today announced that the Company has initiated a new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer. Tesetaxel, the leading oral taxane in clinical development, will be evaluated for its use as both first- and second-line chemotherapy.

10 Feb 2011

Indiana University creates Institute for Personalized Medicine

Indiana University has announced a major commitment to research in one of health care's most promising fields with the creation of the Indiana Institute for Personalized Medicine.

10 Feb 2011

Study: 30% of older patients with vulvar cancer die from treatment complications, ICD

Research by the American Academy of Family Physicians demonstrates that vulvar cancer occurs most frequently in women age 65 to 75 years of age. Thirty percent of patients with vulvar cancer are age 70 or older, and the rate increases with age, reaching a peak of 20 per 100,000 women by 75 years of age.

10 Feb 2011

Cancer Therapy News and Research

ASTRO develops radiation therapy guideline for treating bone metastases

Study analyses number of mortality rates among Spanish women with breast cancer

FAK enzyme plays a key role in preparing lung tissue for metastatic development

Medtronic: Kyphon Balloon Kyphoplasty provides better back pain relief in cancer patients

Sonablate HIFU device is now available in Brazil to treat prostate cancer

Oncolytics begins enrollment in 2-Arm carboplatin Phase II randomized study for pancreatic cancer

First lung cancer treatment with BSD's MicroThermX ablation system delivered at Rhode Island Hospital

Advaxis added to Mentor Capital Cancer Immunotherapy Index

CTI's fourth quarter net loss increases to $34.1 million

RPCI offers first FDA-approved cancer treatment vaccine

US Oncology's PAPs help cancer patients to access high quality care

Oncolytics' REOLYSIN/gemcitabine combination Phase 2 pancreatic cancer trial meets primary endpoint

Researcher discovers mechanism how p53 human genome gets inactivated in cancerous cells

Unmet need for medical help to address sexual issues in breast, gynecologic cancer survivors

State Roundup: Calif. adult day care; S.C.'s budget cuts; Minn. 'boomer bust'

OXiGENE, NCI/CTEP and GOG collaborate on ZYBRESTAT Phase 2 study in relapsed ovarian cancer

Cancer cells 'addicted' to self-preservation process

Genta initiates new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer

Indiana University creates Institute for Personalized Medicine

Study: 30% of older patients with vulvar cancer die from treatment complications, ICD

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News